Biostar Pharmaceuticals (BSPM) Earns Media Sentiment Score of 0.14

Media stories about Biostar Pharmaceuticals (NASDAQ:BSPM) have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Biostar Pharmaceuticals earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 47.0486490036808 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Biostar Pharmaceuticals (NASDAQ:BSPM) traded down $0.02 during mid-day trading on Monday, hitting $2.07. The company’s stock had a trading volume of 66,784 shares, compared to its average volume of 78,028. Biostar Pharmaceuticals has a 1 year low of $1.18 and a 1 year high of $4.30. The stock has a market cap of $5.51, a P/E ratio of 2.98 and a beta of 1.87.

Biostar Pharmaceuticals (NASDAQ:BSPM) last issued its quarterly earnings results on Wednesday, November 15th. The company reported ($0.50) EPS for the quarter. During the same period in the previous year, the company earned ($3.12) earnings per share.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at

About Biostar Pharmaceuticals

Biostar Pharmaceuticals, Inc (Biostar) is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co, Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, manufactures and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China).

Insider Buying and Selling by Quarter for Biostar Pharmaceuticals (NASDAQ:BSPM)

Receive News & Ratings for Biostar Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostar Pharmaceuticals Inc. and related companies with's FREE daily email newsletter.

Leave a Reply